子社群 于重元 [19/19] 劉柯俊 [85/98] 劉滄梧 [119/125] 劉界元(2003-2010) [3/3] 夏和雄(1996-2012) [26/31] 夏興國 [51/54] 姜乃榕 [82/94] 常慧如 [39/44] 張俊彥 [234/254] 張光裕 [69/79] 張憶壽 [103/106] 張文祥 [52/53] 張書銘 [89/91] 彭汪嘉康(1996-2007) [120/126] 施能耀 [37/43] 李家惠 [29/29] 李岳倫 [48/49] 林素芳 [32/32] 楊奕馨 [41/42] 江士昇 [88/90] 沈哲宏 [14/16] 洪文俊 [88/88] 莊雙恩 [82/91] 蔡坤志 [32/34] 蔡慧珍 [66/71] 蘇勇曄 [40/40] 蘇振良 [24/25] 郭靜娟 [71/76] 陳尚鴻 [45/48] 陳振陽 [72/72] 陳立宗 [443/510] 陳美霞(2002-2009) [1/1] 陳詩政 [2/2] 陳雅雯 [38/39] 黃智興 [55/55] 黃道揚 [26/26] 丁兆治(2000-2004) [5/5] 其他 [464/471] 劉敏(1996-2007) [60/62] 劉玫英(2004-2006) [2/2] 吳成文(1996-2008) [53/55] 曾思文(1997-2007) [4/4] 李冠德(1997-2004) [4/6] 林景太(1999-2007) [5/5] 楊文光(1996-1999) [21/21] 王全正(1996-2003) [4/4] 莊聲宏(1997-2004) [11/11] 詹宗晃(2000-2008) [2/2] 賴基銘(2004-2008) [41/47] 阮麗蓉(2000-2006) [6/7] 陳俊叡(2003-2007) [6/6] 馬彥英(1997-1999) [1/1] 黃奇英(2005-2007) [9/10] 鄰近社群 分子與基因醫學研究所 [921/964] 生技與藥物研究所 [830/1008] 生醫工程與奈米醫學研究所 [1214/1334] 免疫醫學研究中心 [224/236] 神經及精神醫學研究中心 [782/804] 細胞及系統醫學研究所 [755/815] 感染症與疫苗研究所 [1541/1618] 群體健康科學研究所 [2870/3000] 國家環境醫學研究所 [1560/1591] 國家蚊媒傳染病防治研究中心 [102/104] 高齡醫學暨健康福祉研究中心 [216/224] 論壇 [2/2] 生醫資源中心 [7/7] 研究生培育合作學程 [188/191] 核心儀器設施中心 [9/9] 病理核心實驗室 [14/14] 實驗動物中心 [8/8] 行政管理部門 [18/18] 社群統計 近3年內發表的文件:335(13.91%) 含全文筆數:2250(93.40%) 文件下載次數統計 下載大於0次:2250(100.00%) 下載大於100次:2250(100.00%) 檔案下載總次數:1614649(30.12%) 最後更新時間: 2024-12-01 03:15 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 Pathological response following neo... Registry of genetic alterations of ... Activated single nucleotide mismatc... Taiwan nationwide study of first-li... The effectiveness of virtual passpo... Special Issue "Bioinformatics ... Evaluating a natural language proce... The clinicopathological significanc... Hypoxia in drug resistance and radi... DKK1 as a chemoresistant protein mo...

跳至: (選擇年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目301-325 / 2409. (共97頁) << < 8 9 10 11 12 13 14 15 16 17 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2022-03-16	Lon upregulation contributes to cisplatin resistance by triggering NCLX-mediated mitochondrial Ca2+ release in cancer cells	Cell Death and Disease. 2022 Mar 16;13(3):Article number 241.
2022-03-16	High stromal SFRP2 expression in urothelial carcinoma confers an unfavorable prognosis	Frontiers in Oncology. 2022 Mar 16;12:Article number 834249.
2022-03-05	Downregulation of ATP binding cassette subfamily a member 10 acts as a prognostic factor associated with immune infiltration in breast cancer	Aging. 2022 Mar 5;14(5):2252-2267.
2022-03-01	Association of smoking with patient characteristics and outcomes in small cell lung carcinoma, 2011-2018	JAMA Network Open. 2022 Mar 1;5(3):Article number e224830.
2022-03	The impact of urate-lowering therapy in post-myocardial infarction patients: Insights from a population-based, propensity score-matched analysis	Clinical Pharmacology and Therapeutics. 2022 Mar;111(3):655-663.
2022-03	SEMRES - A triple security protected blockchain based medical record exchange structure	Computer Methods and Programs in Biomedicine. 2022 Mar;215:Article number 106595.
2022-03	Association between early life laxative exposure and risk of allergic diseases A nationwide matched cohort study	Annals of Allergy, Asthma and Immunology. 2022 Mar;128(3):291-298.e3.
2022-03	Inhibition of KDM4C/c-Myc/LDHA signalling axis suppresses prostate cancer metastasis via interference of glycolytic metabolism	Clinical and Translational Medicine. 2022 Mar;12(3):Article number e764.
2022-03	Editorial: Molecular mechanisms of multiple myeloma	Frontiers in Oncology. 2022 Mar;12:Article number 870123.
2022-02-26	Dysregulated HIC1 and RassF1A expression in vitro alters the cell cytoskeleton and exosomal Piwi-interacting RNA	Biochemical and Biophysical Research Communications. 2022 Feb 26;594:109-116.
2022-02-24	Semaphorin 6C suppresses proliferation of pancreatic cancer cells via inhibition of the AKT/GSK3/beta-catenin/cyclin D1 pathway	International Journal of Molecular Sciences. 2022 Feb 24;23(5):Article number 2608.
2022-02-16	Current status of the spectrum and therapeutics of helicobacter pylori-negative mucosa-associated lymphoid tissue lymphoma	Cancers. 2022 Feb 16;14(4):Article number 1005.
2022-02-15	Semaphorin 4C promotes motility and immunosuppressive activity of cancer cells via CRMP3 and PD-L1	American Journal of Cancer Research. 2022 Feb 15;12(2):713-728.
2022-02-11	Angiogenesis driven by the CEBPD–hsa-miR-429–VEGFA signaling axis promotes urothelial carcinoma progression	Cells. 2022 Feb 11;11(4):Article number 638.
2022-02-10	Prediction model for pancreatic cancer—A population-based study from NHIRD	Cancers. 2022 Feb 10;14(4):Article number 882.
2022-02-02	HDAC6 involves in regulating the lncRNA-microRNA-mRNA network to promote the proliferation of glioblastoma cells	Journal of Experimental and Clinical Cancer Research. 2022 Feb 2;41:Article number 47.
2022-02-01	A prediction model for tumor recurrence in stage II–III colorectal cancer patients: From a machine learning model to genomic profiling	Biomedicines. 2022 Feb 1;10(2):Article number 340.
2022-02-01	Principle-based approach for the de-identification of code-mixed electronic health records	IEEE Access. 2022 Feb;10:22875-22885.
2022-02-01	A phase 3 randomized, double-blind, placebo-controlled study of durvalumab in combination with gemcitabine plus cisplatin (GemCis) in patients (pts) with advanced biliary tract cancer (BTC): TOPAZ-1	Journal of Clinical Oncology. 2022 Feb 01;40(4, Suppl.):378.
2022-02-01	A prospective phase II study of biweekly S-1, leucovorin and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma	Journal of Clinical Oncology. 2022 Feb 01;40(4, Suppl.):550.
2022-02	Comparison of effectiveness and safety between ticagrelor and clopidogrel in patients with acute coronary syndrome and on dialysis in Taiwan	British Journal of Clinical Pharmacology. 2022 Jan;88(1):145-154.
2022-02	Clinical outcomes of Taiwanese patients with resected oral cavity squamous cell carcinoma who underwent Reconstruction with free versus local flaps	Annals of Surgical Oncology. 2022 Feb;29(2):1130-1140.
2022-02	Incidence and survival variations of upper tract urothelial cancer in Taiwan (2001-2010)	International Journal of Urology. 2022 Feb;29(2):121-127.
2022-02	Fracture risks in patients with atopic dermatitis: A nationwide matched cohort study—reply	Annals of Allergy, Asthma and Immunology. 2022 Feb;128(2):Article number 231.
2022-02	Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): A randomised, multicentre, double-blind, placebo-contr	Lancet Oncology. 2022 Feb;23(2):234-247.

顯示項目301-325 / 2409. (共97頁) << < 8 9 10 11 12 13 14 15 16 17 > >> 每頁顯示[10|25|50]項目